Childhood cancer: an equity test for global health
Affiliations & Notes
aDepartment of Rehabilitation and Health Services, College of Health and Public Service, University of North Texas, Denton, TX 76203-5017, USA
bDepartment of Epidemiology, University of California, Los Angeles, CA, USA
cDepartment of Pharmacy Practice, Faculty of Pharmacy, Ahram Canadian University, 6th of October City, Egypt
dDepartment of Military and Community Medicine, Phramongkutklao College of Medicine, Bangkok, Thailand
eFunctional Cancer Genomics Laboratory, National Institute of Genomic Medicine of Mexico, Mexico City, Mexico
Article Info
Publication History:
Published April 4, 2026
DOI: 10.1016/S0140-6736(25)02376-1 External LinkAlso available on ScienceDirect External Link
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Linked Articles
Download started
OkThe incidence of paediatric cancers has been difficult to assess, due both to the nature of these cancers and to inadequate data availability. Globally, only 21% of the population lives in areas with population-based cancer registries, some with varying data quality or passive follow-up; 38% of the global population lives in areas with death registration.1,2 Furthermore, childhood cancers are best classified by their morphology rather than by their site, necessitating pathological review for accurate diagnosis. Consequently, there is a limited and unclear picture of the global burden of childhood cancers especially for specific subtypes. In The Lancet, Lisa M Force and collaborators of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) partly address this gap by providing updated global estimates of the incidence, mortality, and disability-adjusted life years (DALYs) of cancer in children aged 0–19 years from 1990 to 2023.3
References
1.
The Lancet
Cancer registries: the bedrock of global cancer care
Lancet. 2025; 405:353
2.
Mikkelsen, L ∙ Phillips, DE ∙ AbouZahr, C ∙ et al.
A global assessment of civil registration and vital statistics systems: monitoring data quality and progress
Lancet. 2015; 386:1395-1406
3.
GBD 2023 Childhood Cancer Collaborators
Global burden of cancer in children and adolescents aged 0–19 years, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
Lancet. 2026; 407:1360-1373
4.
Piñeros, M ∙ Mery, L ∙ Soerjomataram, I ∙ et al.
Scaling up the surveillance of childhood cancer: a global roadmap
J Natl Cancer Inst. 2021; 113:9-15
5.
GBD 2017 Childhood Cancer Collaborators
The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017
Lancet Oncol. 2019; 20:1211-1225
6.
Lam, CG ∙ Howard, SC ∙ Bouffet, E ∙ et al.
Science and health for all children with cancer
Science. 2019; 363:1182-1186
7.
Geel, JA ∙ Challinor, J ∙ Ranasinghe, N ∙ et al.
Pediatric cancer care in Africa: SIOP Global Mapping Program report on economic and population indicators
Pediatr Blood Cancer. 2021; 68, e29345
8.
Siddiqui, AK ∙ Belgaumi, AF
Paediatric oncology in the Eastern Mediterranean region (EMR): the current state and challenges
Ecancermedicalscience. 2024; 18, 1677
9.
Balagadde-Kambugu, J ∙ Davidson, A ∙ Hessissen, L ∙ et al.
Toward 2030: SIOP Africa adopts the Global Initiative for Childhood Cancer
Pediatr Hematol Oncol. 2023; 40:197-202
10.
Khan, MS ∙ Al-Jadiry, MF ∙ Tarek, N ∙ et al.
Pediatric oncology infrastructure and workforce training needs: a report from the Pediatric Oncology East and Mediterranean (POEM) Group
Pediatr Blood Cancer. 2021; 68, e29190
11.
Ortiz, R ∙ Vásquez, L ∙ Giri, B ∙ et al.
Developing and sustaining high-quality care for children with cancer: the WHO Global Initiative for Childhood Cancer
Rev Panam Salud Publica. 2023; 47:e164
12.
Steliarova-Foucher, E ∙ Colombet, M ∙ Ries, LAG ∙ et al. (Editors)
International Incidence of Childhood Cancer
International Agency for Research on Cancer, Lyon, France, Volume III. 2017
13.
Sayeed, S ∙ Barnes, I ∙ Ali, R
Childhood cancer incidence by ethnic group in England, 2001–2007: a descriptive epidemiological study
BMC Cancer. 2017; 17:570
14.
Vásquez, L ∙ Montoya, J ∙ Ugaz, C ∙ et al.
ONCOPEDS: A mobile application to improve early diagnosis and timely referral in childhood cancer in a low- and middle-income country—a pilot study
Pediatr Blood Cancer. 2021; 68, e28908
15.
Hudson, MM ∙ Ness, KK ∙ Gurney, JG ∙ et al.
Clinical ascertainment of health outcomes among adults treated for childhood cancer
JAMA. 2013; 309:2371-2381
16.
Bhatt, NS ∙ Goodman, P ∙ Leisenring, WM ∙ et al.
Chronic health conditions and longitudinal employment in survivors of childhood cancer
JAMA Netw Open. 2024; 7, e2410731
Facts Only
The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023 provides updated estimates of childhood cancer incidence, mortality, and DALYs from 1990 to 2023.
Only 21% of the global population lives in areas with population-based cancer registries.
38% of the global population lives in areas with death registration systems.
Childhood cancers are best classified by morphology rather than site, requiring pathological review for accurate diagnosis.
The GBD 2023 study focuses on children aged 0–19 years.
The study was published in *The Lancet* on April 4, 2026.
The WHO Global Initiative for Childhood Cancer aims to improve care and surveillance for childhood cancers.
Low- and middle-income countries face challenges in diagnostic infrastructure and workforce training.
The article references multiple studies and initiatives, including the SIOP Global Mapping Program and the Pediatric Oncology East and Mediterranean (POEM) Group.
Childhood cancer incidence varies by ethnic group and region, as shown in studies from England and other countries.
Survivors of childhood cancer often face chronic health conditions and employment challenges later in life.
Executive Summary
Full Take
The strongest version of this narrative highlights a critical gap in global health equity: childhood cancer remains understudied and underreported, particularly in regions lacking robust healthcare infrastructure. The GBD 2023 study provides valuable data, but its limitations—such as reliance on incomplete registries—underscore the systemic challenges in addressing this issue. The article rightly emphasizes the need for improved surveillance, diagnostic tools, and workforce training, framing childhood cancer as a test of global health equity.
However, the narrative could be vulnerable to distortion if framed as a purely technical problem rather than a systemic one. For example, focusing solely on data gaps without addressing underlying disparities in healthcare access might lead to superficial solutions. The article avoids emotional exploitation but could benefit from deeper exploration of root causes, such as economic barriers to care in low-income countries.
Root cause: The paradigm driving this narrative is the tension between global health aspirations and local realities. The assumption that better data alone will solve the problem ignores structural inequities in resource allocation. Historically, childhood cancer has been overshadowed by adult cancers in funding and research, echoing broader patterns of neglect for pediatric health in global policy.
Implications: If unaddressed, these disparities will perpetuate preventable suffering, with long-term costs for survivors and societies. The benefits of improved surveillance accrue to policymakers and researchers, while the costs—delayed diagnoses, untreated cases—are borne by vulnerable populations.
Bridge questions: How might global health initiatives better integrate local knowledge and infrastructure? What role should high-income countries play in supporting equitable access to childhood cancer care? Would a shift from data-focused to systems-focused solutions yield better outcomes?
Counterstrike scan: A bad actor might exploit this narrative to push for top-down, one-size-fits-all solutions that disregard local contexts. The actual content does not match this pattern, as it acknowledges regional disparities and the need for tailored interventions.
Patterns detected: none
Sentinel — Human
While the text shows some signs of being written by a human, the analysis indicates that it is likely human-written.